DILH
ENTA icon

Dai-ichi Life Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History

Dai-ichi Life Holdings’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-30,358
Closed -$1.54M – 659
2014
Q4 		$1.54M Sell
30,358
-3,150
-9% -$141K 0.04% 374
2014
Q3 		$1.33M Sell
33,508
-637
-2% -$25.4K 0.04% 381
2014
Q2 		$1.47M Sell
34,145
-697
-2% -$26.6K 0.05% 369
2014
Q1 		$1.39M Buy
+34,842
New +$1.27M 0.04% 358

Other funds holding ENTA

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MVM
McClain Value Management New Canaan, Connecticut $50.9M AUM 16.06% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dai-ichi Life Holdings's ENTA Position: Q1 2015 in Review

Dai-ichi Life Holdings sold out of Enanta Pharmaceuticals (ENTA) in Q1 2015, closing a stake of 30,358 shares — an estimated $1.54M sold.

Dai-ichi Life Holdings first reported a position in ENTA in Q1 2014 and held it in 4 quarters. The position peaked at $1.54M in Q4 2014. 117 funds tracked by Wall St. Rank hold ENTA as of Q1 2015.

  • Dai-ichi Life Holdings reported no remaining Enanta Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 30,358 Enanta Pharmaceuticals shares in Q1 2015, an estimated $1.54M.
  • Dai-ichi Life Holdings first reported a position in Enanta Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Dai-ichi Life Holdings's Enanta Pharmaceuticals position peaked at $1.54M in Q4 2014.
  • 117 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2015.

Based on Dai-ichi Life Holdings's 13F filing for Q1 2015, filed 5 May 2015.